About BioSpecifics Technologies Corp

A pharmaceutical company with a major focus on wound healing and tissue remodeling.

Pioneering the application of Collagenase for the treatment of diseases.

• Dermal ulcers
• Pressure sores (bedsores)
• Second and third degree burns
• Dupuytren's Disease
• Peyronie's Disease
• Glaucoma
• Spinal Disk Disease
• And Others

Product Marketing

BioSpecifics produces Collagenase ABC, the essential ingredient in the prescription drug Collagenase
Santyl® sold in the United States, and under other trademarks abroad. Package Insert.

Injectable collagenase
Based on BioSpecifics' proprietary understanding of collagenase production, its extensive patent position, and the therapeutic potential of collagenase, clinical trials are underway in the U.S. for the use of injectable collagenase. Applications for governmental approval have been filed in several countries overseas.

Topical Collagenase
Clinical and laboratory investigations further exploring and defining the potential role of Collagenase and its pharmacological activity in wound healing are being actively pursued.